Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1

被引:108
|
作者
Armaka, M [1 ]
Papanikolaou, E [1 ]
Sivropoulou, A [1 ]
Arsenakis, M [1 ]
机构
[1] Aristotelian Univ Salonika, Lab Gen Microbiol, Sect Genet Dev & Mol Biol, Sch Biol, GR-54006 Salonika, Greece
关键词
anti-herpes simplex virus agents; antiviral agents; borneol; essential oil; glycoproteins of HSV-1; glycosylation; glycosylation inhibitors; herpes simplex virus 1; HSV-1; isoborneol; monoterpenes; Salvia fruticosa; specific inhibitors of viral glycosylation; transformed Vero cells;
D O I
10.1016/S0166-3542(99)00036-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Isoborneol, a monoterpene and a component of several plant essential oils, showed dual viricidal activity against herpes simplex virus 1 (HSV-1). First, it inactivated HSV-1 by almost 4 log(10) values within 30 min of exposure, and second, isoborneol at a concentration of 0.06% completely inhibited viral replication, without affecting viral adsorption. Isoborneol did not exhibit significant cytotoxicity at concentrations ranging between 0.016% and 0.08% when tested against human and monkey cell lines. Isoborneol specifically inhibited glycosylation of viral polypeptides based on the following data: (1) the mature fully glycosylated forms of two viral glycoproteins gB and go were not detected when the virus was replicated in the presence of isoborneol, (2) no major changes were observed in the glycosylation pattern of cellular polypeptides between untreated and isoborneol treated Vero cells, (3) isoborneol did not affect the glycosylation of gB produced from a copy of the gB gene resident in the cellular genome, and (4) other monoterpenes such as 1,8-cineole and borneol, a stereoisomer of isoborneol, did not inhibit HSV-I glycosylation. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:79 / 92
页数:14
相关论文
共 50 条
  • [41] Antiviral action of trichosanthin on herpes simplex virus
    Tam, SC
    Chan, WL
    Chan, P
    Zheng, YT
    FASEB JOURNAL, 2000, 14 (04): : A184 - A184
  • [42] Advances in herpes simplex virus antiviral therapies
    Mamidyala, Sreeman K.
    Firestine, Steven M.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (11) : 1463 - 1480
  • [43] Resistance of herpes simplex virus to antiviral drugs
    Coen, DM
    CURRENT OPINION IN INFECTIOUS DISEASES, 1995, 8 (06) : 489 - 492
  • [44] Plant extracts antiviral activity against Herpes simplex virus type 1 and African swine fever virus
    Silva, O
    Barbosa, S
    Diniz, A
    Valdeira, ML
    Gomes, E
    INTERNATIONAL JOURNAL OF PHARMACOGNOSY, 1997, 35 (01): : 12 - 16
  • [45] Antiviral Properties of R. tanguticum Nanoparticles on Herpes Simplex Virus Type I In Vitro and In Vivo
    Shen, Meng-xin
    Ma, Nian
    Li, Min-ke
    Liu, Yuan-yuan
    Chen, Tian
    Wei, Fei
    Liu, Dong-ying
    Hou, Wei
    Xiong, Hai-rong
    Yang, Zhan-qiu
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [46] Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
    Heilingloh, Christiane Silke
    Lull, Christopher
    Kleiser, Elissa
    Alt, Mira
    Schipper, Leonie
    Witzke, Oliver
    Trilling, Mirko
    Eis-Huebinger, Anna-Maria
    Dittmer, Ulf
    Krawczyk, Adalbert
    VACCINES, 2020, 8 (03) : 1 - 11
  • [47] Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: Predictions of mathematical models
    Lipsitch, M
    Bacon, TH
    Leary, JJ
    Antia, R
    Levin, BR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) : 2824 - 2835
  • [48] ANTIVIRAL ACTIVITY OF AN ADENOSINE DEAMINASE INHIBITOR - DECREASED REPLICATION OF HERPES-SIMPLEX VIRUS
    WILLIAMS, BB
    LERNER, AM
    JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (06): : 673 - 677
  • [49] Antiviral activity of Spirulina maxima against herpes simplex virus type 2
    Hernández-Corona, A
    Nieves, I
    Meckes, M
    Chamorro, G
    Barron, BL
    ANTIVIRAL RESEARCH, 2002, 56 (03) : 279 - 285
  • [50] The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1
    Biswas, Subhajit
    Jennens, Lyn
    Field, Hugh J.
    ANTIVIRAL RESEARCH, 2007, 75 (01) : 30 - 35